Modern Healthcare News
 
RSS feed

Pharmaceuticals news and information

News
New restrictions on hydrocodone to take effect
By Associated Press | August 21, 2014 | Basic Web Basic Web Subscription Details
The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
FULL STORY »
 

Magazine
Richest healthcare tycoons dominated by pharmaceutical execs
By Modern Healthcare | August 16, 2014 | Print Magazine Print Magazine Subscription Details
Who's the richest of them all? When Outliers dug into real-time data from Forbes on billionaires, some familiar and not-so-familiar names popped up in the healthcare field for the U.S.
FULL STORY »
 

Magazine
History and the Ebola outbreak
By Merrill Goozner, Editor | August 16, 2014 | Print Magazine Print Magazine Subscription Details
One cannot help but be moved by the heart-rending stories and desperate pleas coming from the four African countries enduring an Ebola outbreak, which has already killed more than 1,000 people.
FULL STORY »
 

Information
Ebola puts focus on drugs made in tobacco plants
By Associated Press | August 15, 2014
It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. Using plants this way—sometimes called "pharming"—can produce complex and valuable proteins for medicines.
FULL STORY »
 

News
Ebola cure scams are out there; beware, FDA warns
By Steven Ross Johnson | August 14, 2014 | Basic Web Basic Web Subscription Details
The Food and Drug Administration on Thursday issued a warning to the public after receiving consumer complaints of products being sold online claiming to prevent or treat the Ebola virus that has killed more than 1,000 people across four countries in West Africa.
FULL STORY »
 


Advertisement | View Media Kit

News
Ebola drug supply exhausted after shipments to Africa, company says
By Steven Ross Johnson | August 12, 2014 | Basic Web Basic Web Subscription Details
The company that developed an experimental drug used against the Ebola virus said it has exhausted its supply after shipping doses to Africa to treat two Liberian doctors.
FULL STORY »
 

Information
Tekmira stock soars after FDA relaxes precautions on experimental Ebola drug
By Canadian Press via Victoria (B.C.) Times Colonist | August 09, 2014
Shares of Tekmira Pharmaceuticals Corp. shot up about 47% Friday following a U.S. regulatory decision that relaxes safety precautions on the Vancouver-based company's experimental drug for treating Ebola.
FULL STORY »
 

Magazine
Sovaldi's cost-effectiveness is being overplayed
By Merrill Goozner, Editor | August 09, 2014 | Print Magazine Print Magazine Subscription Details
Sovaldi will not save the healthcare system money. It will cost money—a lot of money—to reduce premature mortality due to chronic hepatitis C infection.
FULL STORY »
 

News
FDA gives go-ahead for partial testing of new Ebola drug
By Steven Ross Johnson | August 08, 2014 | Basic Web Basic Web Subscription Details
A Vancouver-based pharmaceutical firm says government regulators have eased safety restrictions on its experimental Ebola drug treatment, raising the possibility of its use in those infected with the virus.
FULL STORY »
 

News
Suspect HIV drug prescriptions cost Medicare millions
By Bob Herman | August 06, 2014 | Basic Web Basic Web Subscription Details
Medicare paid $32 million in 2012 for HIV drugs that were tied to questionable and potentially fraudulent uses, according to a new report from HHS' Office of Inspector General. In some instances, there was no indication the beneficiaries had HIV.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.